.png)
Agenzia Italiana del Farmaco
Hepatitis C: update of 14 March 2022 concerning enrolled patients - Hepatitis C: update of 14 March 2022 concerning enrolled patients
Hepatitis C: update of 14 March 2022 concerning enrolled patients
AIFA has published the updated weekly data concerning treatments with new second-generation direct acting antiviral agents (DAAs) for chronic hepatitis C, as collected by AIFA Monitoring registries.
The information is contained in the page "Update on hepatitis C" accessible through the box "Related links".
Published on: 14 March 2022
Contacts
Via del Tritone, 181 00187 Roma
VAT number: 08703841000
Tax code: 97345810580
IPA AIFA code: aifa_rm
IPA UCB code: UFE1TR